Fidelity Advisor Biotechnology Fund TVTX Holdings History
Fidelity Advisor Biotechnology Fund's Travere Therapeutics Inc Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 83,243.00 shares of Travere Therapeutics Inc(TVTX), totaling $790,810.00. This investment constitutes 0.06% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.09% of the outstanding Travere Therapeutics Inc(TVTX) stock.
The initial trade took place in 2020Q1. And since then Fidelity Advisor Biotechnology Fund has made 3 purchases of TVTX, at an average price of $17.80, for a total of 4.04 Mil shares. In addition, there have been 2 sales at an average price of $15.97 for 1.24 Mil shares. Based on historical transaction data and TVTX's current price of $16.11, Fidelity Advisor Biotechnology Fund's estimated gain on his TVTX holdings is $-6.99 Mil, reflecting a -9.72% gain to date.
Fidelity Advisor Biotechnology Fund TVTX ($16.11) Holding Chart
Fidelity Advisor Biotechnology Fund TVTX ($16.11) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
